CUSIP 02155H200COM NEWALTQ4 2025
18 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | May 1, 2026 | Lawver Teri L | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 2 | May 1, 2026 | Pisano Wayne | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 3 | May 1, 2026 | Schafer Klaus | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K |
See the full Form 4 transaction history for Altimmune Inc.
Unlock all transactions| SEC |
| 4 | May 1, 2026 | Hodges Philip | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 5 | May 1, 2026 | Sohn Catherine A. | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 6 | May 1, 2026 | Jorkasky Diane | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 7 | May 1, 2026 | Gill John | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 8 | May 1, 2026 | Sayare Mitchel | Director | A · Grant | 48.8K | $0.00 | $0 | 48.8K | SEC |
| 9 | Sep 12, 2018 | Novartis Bioventures Ltd | 10% Owner | J · J | 2.07M | $0.00 | $0 | 8.35M | SEC |
| 10 | Sep 12, 2018 | Novartis Bioventures Ltd | 10% Owner | J · J | 465.1K | $0.00 | $0 | 0 | SEC |